Healthcare Trust of America Stock Price Target and Analyst Ratings (NYSE:HTA)

Analyst Price Target for HTA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$29.70

▲ +3.13% Upside Potential

This price target is based on 13 analysts offering 12 month price targets for Healthcare Trust of America in the last 3 months. The average price target is $29.70, with a high forecast of $38.00 and a low forecast of $24.00. The average price target represents a 3.13% upside from the last price of $28.80.

Buy

The current consensus among 13 investment analysts is to buy stock in Healthcare Trust of America. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
5 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

7/30/2019

0 strong buy ratings
6 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

10/28/2019

0 strong buy ratings
7 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

1/26/2020

0 strong buy ratings
7 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

4/25/2020

0 strong buy ratings
6 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

7/24/2020

0 strong buy ratings
6 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

10/22/2020

0 strong buy ratings
7 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

12/21/2020

0 strong buy ratings
8 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

1/20/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
1/20/2021	Capital One Financial	Downgrade	Overweight ➝ Equal Weight		Low	i
1/13/2021	Jefferies Financial Group	Boost Price Target	Buy	$33.00 ➝ $35.00	High	i
12/21/2020	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$29.00	Low	i
12/15/2020	Smith Barney Citigroup	Upgrade	Neutral ➝ Buy		Low	i
12/15/2020	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Upgrade	Neutral ➝ Buy	$28.00 ➝ $29.00	Medium	i
9/1/2020	Stifel Nicolaus	Reiterated Rating	Buy	$32.00	Medium	i
8/31/2020	Raymond James	Upgrade	Market Perform ➝ Outperform	$29.00	Low	i
7/2/2020	Citigroup	Boost Price Target	Neutral	$25.00 ➝ $28.00	Low	i
5/6/2020	BMO Capital Markets	Reiterated Rating	Buy	$38.00	Medium	i Rating by John Kim at BMO Capital Markets
4/23/2020	SunTrust Banks	Lower Price Target	Buy	$33.00 ➝ $27.00	Low	i
4/7/2020	Citigroup	Lower Price Target	Neutral	$34.00 ➝ $25.00	Low	i
4/3/2020	Wells Fargo & Company	Lower Price Target	Overweight	$32.00 ➝ $26.00	Low	i
4/3/2020	JPMorgan Chase & Co.	Lower Price Target	Overweight	$33.00 ➝ $27.00	Low	i Rating by Anthony Paolone at JPMorgan Chase & Co.
3/26/2020	Morgan Stanley	Lower Price Target	Equal Weight	$30.00 ➝ $24.00	High	i
3/16/2020	BTIG Research	Downgrade	Buy ➝ Neutral		High	i
3/3/2020	JPMorgan Chase & Co.	Boost Price Target	Overweight	$32.00 ➝ $33.00	Low	i Rating by Anthony Paolone at JPMorgan Chase & Co.
2/20/2020	Citigroup	Boost Price Target	Neutral	$31.00 ➝ $34.00	Medium	i
1/7/2020	BMO Capital Markets	Upgrade	Market Perform ➝ Outperform	$33.00 ➝ $35.00	Low	i
12/20/2019	Mizuho	Reiterated Rating	Buy	$35.00	Low	i
12/18/2019	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$31.00 ➝ $32.00	Low	i
11/26/2019	Stifel Nicolaus	Upgrade	Hold ➝ Buy	$30.00 ➝ $33.00	High	i
10/29/2019	Cfra	Downgrade	Buy ➝ Hold		Medium	i
10/29/2019	BMO Capital Markets	Reiterated Rating	Hold	$28.00	Low	i
9/12/2019	Berenberg Bank	Initiated Coverage	Buy	$33.00	Medium	i
6/20/2019	Citigroup	Initiated Coverage	Neutral ➝ Neutral	$29.00	Low	i
5/13/2019	Raymond James	Upgrade	Market Perform ➝ Outperform		Medium	i
4/10/2019	SunTrust Banks	Lower Price Target	Buy	$30.00	Medium	i
3/29/2019	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$30.00 ➝ $33.00	Medium	i
3/28/2019	Morgan Stanley	Set Price Target	Hold	$29.00	Low	i Rating by Vikram Malhorta at Morgan Stanley
2/15/2019	Capital One Financial	Upgrade	Equal Weight ➝ Overweight		Medium	i Rating by D. Bernstein at Capital One Financial Co.
2/14/2019	BMO Capital Markets	Reiterated Rating	Hold	$28.00	Medium	i
1/9/2019	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$30.00 ➝ $28.00	Low	i
12/13/2018	Jefferies Financial Group	Downgrade	Buy ➝ Hold		Medium	i
11/13/2018	Mizuho	Upgrade	Neutral ➝ Buy	$32.00	Low	i
10/29/2018	SunTrust Banks	Lower Price Target	Buy ➝ Buy	$32.00 ➝ $30.00	Low	i
8/29/2018	JPMorgan Chase & Co.	Boost Price Target	Neutral ➝ Neutral	$28.00 ➝ $29.00	Low	i
8/16/2018	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$27.00 ➝ $26.00	Medium	i
8/13/2018	Jefferies Financial Group	Reiterated Rating	Buy	$34.00	Low	i
7/10/2018	Mitsubishi UFJ Financial Group	Reiterated Rating	Overweight ➝ Neutral	$30.00 ➝ $28.00	Low	i Rating by K. Ford at Mitsubishi UFJ Financial Group
6/14/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$30.00 ➝ $27.00	Low	i
6/1/2018	Raymond James	Reiterated Rating	Market Perform		Low	i Rating by Jonathan Hughes at Raymond James
5/21/2018	Raymond James	Downgrade	Outperform ➝ Market Perform		Low	i Rating by Jonathan Hughes at Raymond James
4/24/2018	Stifel Nicolaus	Downgrade	Buy ➝ Hold		Medium	i Rating by Chad Vanacore at Stifel Nicolaus
3/26/2018	BMO Capital Markets	Set Price Target	Buy	$31.00	Low	i Rating by John Kim at BMO Capital Markets
3/26/2018	Jefferies Financial Group	Reiterated Rating	Buy	$32.00	Low	i
3/20/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$33.00 ➝ $30.00	Medium	i
2/27/2018	Raymond James	Downgrade	Strong-Buy ➝ Outperform	$34.00 ➝ $30.00	Low	i
2/23/2018	Jefferies Financial Group	Reiterated Rating	Buy		Low	i
2/20/2018	Mizuho	Downgrade	Buy ➝ Neutral	$32.00	Medium	i
2/16/2018	Stifel Nicolaus	Lower Price Target	Hold ➝ Hold	$35.00 ➝ $32.00	High	i Rating by Chad Vanacore at Stifel Nicolaus
1/22/2018	SunTrust Banks	Set Price Target	Buy	$33.00	Low	i Rating by Eric Fleming at SunTrust Banks, Inc.
1/9/2018	BMO Capital Markets	Reiterated Rating	Buy	$33.00	Medium	i
12/13/2017	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight		Low	i
10/29/2017	Mitsubishi UFJ Financial Group	Reiterated Rating	Overweight		N/A	i Rating by K. Ford at Mitsubishi UFJ Financial Group
10/25/2017	Stifel Nicolaus	Boost Price Target	Hold ➝ Hold	$34.00 ➝ $35.00	N/A	i
10/24/2017	SunTrust Banks	Set Price Target	Buy	$36.00	N/A	i Rating by Eric Fleming at SunTrust Banks, Inc.
10/11/2017	(FBRC)	Set Price Target	Hold	$32.00	N/A	i Rating by C. Kucera at (FBRC)
10/4/2017	Mizuho	Reiterated Rating	Buy	$36.00	Low	i
10/3/2017	Jefferies Financial Group	Reiterated Rating	Buy	$34.00	Low	i
10/2/2017	BMO Capital Markets	Reiterated Rating	Buy	$35.00	Low	i Rating by John Kim at BMO Capital Markets
9/25/2017	Capital One Financial	Reiterated Rating	Equal Weight	$31.00	Low	i Rating by D. Bernstein at Capital One Financial Co.
7/17/2017	Raymond James	Upgrade	Outperform ➝ Strong-Buy	$35.00	Low	i
7/17/2017	UBS Group	Upgrade	Outperform ➝ Strong-Buy		Low	i
7/12/2017	Stifel Nicolaus	Lower Price Target	Buy	$36.00 ➝ $34.00	Low	i
7/11/2017	(FBRC)	Initiated Coverage	Mkt Perform	$32.00	Low	i Rating by C. Kucera at (FBRC)
6/27/2017	Mizuho	Reiterated Rating	Buy		Medium	i
6/20/2017	BMO Capital Markets	Upgrade	Market Perform ➝ Outperform	$33.00 ➝ $35.00	Low	i Rating by John Kim at BMO Capital Markets
6/16/2017	Wells Fargo & Company	Reiterated Rating	Outperform	$33.50 ➝ $35.00	Low	i
6/5/2017	Jefferies Financial Group	Upgrade	Buy	$36.00	Low	i
5/15/2017	BMO Capital Markets	Set Price Target	Hold	$33.00	Low	i Rating by John Kim at BMO Capital Markets
5/4/2017	(MTU)	Reiterated Rating	Buy		Medium	i
5/3/2017	Mitsubishi UFJ Financial Group	Reiterated Rating	Buy		High	i Rating by Karin Ford at Mitsubishi UFJ Financial Group
5/1/2017	Jefferies Financial Group	Boost Price Target	Buy	$35.00 ➝ $36.00	High	i
4/12/2017	BMO Capital Markets	Reiterated Rating	Hold	$33.00	Low	i
1/4/2017	Mizuho	Upgrade	Neutral ➝ Buy	$29.00 ➝ $32.00	N/A	i
12/16/2016	Jefferies Financial Group	Initiated Coverage	Buy	$33.00	N/A	i
11/7/2016	Raymond James	Upgrade	Market Perform ➝ Outperform	$33.00	N/A	i
11/7/2016	UBS Group	Upgrade	Market Perform ➝ Outperform		N/A	i
8/25/2016	BTIG Research	Initiated Coverage	Buy	$37.00	N/A	i
8/8/2016	Mizuho	Lower Price Target	Neutral	$34.00 ➝ $28.00	N/A	i
8/3/2016	Wunderlich	Boost Price Target	Hold	$28.50 ➝ $31.00	N/A	i Rating by Craig Kucera at Wunderlich
8/2/2016	Oppenheimer	Boost Price Target	Outperform	$37.00 ➝ $38.00	N/A	i
4/27/2016	Wunderlich	Reiterated Rating	Hold	$25.00 ➝ $28.50	N/A	i
4/26/2016	Stifel Nicolaus	Boost Price Target	Buy	$29.00 ➝ $31.00	N/A	i Rating by Daniel Bernstein at Stifel Nicolaus
3/23/2016	BMO Capital Markets	Boost Price Target	Market Perform	$29.00	N/A	i
3/21/2016	SunTrust Banks	Initiated Coverage	Buy	$32.00	N/A	i
2/22/2016	Mizuho	Boost Price Target	Neutral	$26.00 ➝ $28.00	N/A	i

(Data available from 1/20/2016 forward)

Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 25.1 million square feet of GLA, with $7.4 billion invested primarily in MOBs. HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations. Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth. The strategic markets HTA invests in support a strong, long-term demand for quality medical office space. HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market. This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation. Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level. Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the US REIT index.

Today's Range

Now: $28.80

$27.94

$29.09

50 Day Range

MA: $26.96

$25.72

$28.59

52 Week Range

Now: $28.80

$20.61

$34.22

Volume

1,180,573 shs

Average Volume

2,398,079 shs

Market Capitalization

$6.29 billion

P/E Ratio

192.00

Dividend Yield

4.54%

Beta

0.58

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthcare Trust of America?

The following Wall Street sell-side analysts have issued research reports on Healthcare Trust of America in the last year: BMO Capital Markets, BTIG Research, Capital One Financial Co., Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Raymond James, Smith Barney Citigroup, Stifel Nicolaus, SunTrust Banks, Inc., Wells Fargo & Company, and Zacks Investment Research.

What is the current price target for Healthcare Trust of America?

10 Wall Street analysts have set twelve-month price targets for Healthcare Trust of America in the last year. Their average twelve-month price target is $29.70, suggesting a possible upside of 4.6%. BMO Capital Markets has the highest price target set, predicting HTA will reach $38.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $24.00 for Healthcare Trust of America in the next year.

What is the current consensus analyst rating for Healthcare Trust of America?

Healthcare Trust of America currently has 5 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HTA will outperform the market and that investors should add to their positions of Healthcare Trust of America.

What other companies compete with Healthcare Trust of America?

Other companies that are similar to Healthcare Trust of America include Weyerhaeuser, Alexandria Real Estate Equities, AvalonBay Communities, Equity Residential, Realty Income, Ventas, Healthpeak Properties, Essex Property Trust, Sun Communities, Mid-America Apartment Communities, Extra Space Storage, Boston Properties, Duke Realty, HCP and VICI Properties.

How do I contact Healthcare Trust of America's investor relations team?

Healthcare Trust of America's physical mailing address is 16435 N. SCOTTSDALE ROAD SUITE 320, SCOTTSDALE AZ, 85254. The real estate investment trust's listed phone number is 480-998-3478 and its investor relations email address is info@htareit.com. The official website for Healthcare Trust of America is www.htareit.com.

NYSE:HTA - Healthcare Trust of America Stock Price Target and Predictions

Analyst Price Target for HTA

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthcare Trust of America?

What is the current price target for Healthcare Trust of America?

What is the current consensus analyst rating for Healthcare Trust of America?

What other companies compete with Healthcare Trust of America?

How do I contact Healthcare Trust of America's investor relations team?